Article
Studying Triple Negative Breast Cancer Using Orthotopic Breast Cancer Model.
Journal of visualized experiments : JoVE - 20 Mar 2020
Cheng Robert Y S, Patel Nimit L, Back Timothy, Basudhar Debashree, Somasundaram Veena, Kalen Joseph D, Wink David A, Ridnour Lisa A
Abstract excerpt
Triple-negative breast cancer (TNBC) is an aggressive breast cancer subtype with limited therapeutic options. When compared to patients with less aggressive breast tumors, the 5-year survival rate of TNBC patients is 77% due to their characteristic drug-resistant phenotype and metastatic burden. Toward this end, murine models have been established aimed at identifying novel therapeutic strategies limiting TNBC...
Topics
- Animals
- Antineoplastic Agents
- Cell Line, Tumor
- Drug Resistance, Neoplasm
- Female
- Humans
- Lung Neoplasms
- Mice
- Phenotype
- Triple Negative Breast Neoplasms
- Xenograft Model Antitumor Assays
